TAF10 and cancer: Several MYC inhibitors have been recently developed, including small molecules (BEZ235,[49] MYCi361,[50] MYCi975[21]) and monoclonal antibodies.[51] We discovered a new anti‐cancer small molecule, Z363, co‐regulating TAF10 and MYC.